Leukopoietic stimulation by testosteron in cancer patients treated by chemotherapy and irradiation.
D000230:Adenocarcinoma / Q000628:therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000628:therapy; D001984:Bronchial Neoplasms / Q000628:therapy; D002277:Carcinoma / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007273:Injections, Intramuscular; D007680:Kidney Neoplasms / Q000628:therapy; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control*; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy; D010051:Ovarian Neoplasms / Q000628:therapy; D010255:Paranasal Sinus Neoplasms / Q000628:therapy; D011878:Radiotherapy / Q000009:adverse effects; D012512:Sarcoma, Ewing / Q000628:therapy; D013739:Testosterone / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents; D013739:Testosterone